NM_001399.5:c.2T>C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001399.5(EDA):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001399.5 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Hypohidrotic X-linked ectodermal dysplasia Pathogenic:1
The Met1Thr variant in EDA has been reported in at least 2 individuals with X-li nked hypohidrotic ectodermal dysplasia (XLHED). In addition, other variants dis rupting the start codon (Met) have been reported in individuals with XLHED (Met1 Lys, Met1Arg, Met1Leu; Cluzeau 2011, van der Hout 2008, Vincent 2001, Zhao 2008) . These variants are predicted to result in the loss of translation initiation and therefore, a loss of protein production. In summary, this variant is highly likely to be pathogenic. The presence of a hemizygous pathogenic variant in EDA is consistent with a diagnosis of X-Linked Hypohidrotic Ectodermal Dysplasia, b ut this information should be reconciled with the complete clinical history of t his individual. -
Hypohidrotic X-linked ectodermal dysplasia;C1970757:Tooth agenesis, selective, X-linked, 1 Pathogenic:1
PVS1, PM2, PS4_Moderate -
not provided Pathogenic:1
The c.2 T>C pathogenic variant in the EDA1 gene has been reported previously in association with X-linked hypohidrotic ectodermal dysplasia (Zhao et al., 2008), and has been observed in multiple individuals at GeneDx. The pathogenic variant alters the initiator Methionine codon, and the resultant protein would be described as p.Met1? using a question mark to signify that it is not known if the loss of Met1 means that all protein translation is completely prevented or if an abnormal protein is produced using an alternate Met. Additionally, the c.2 T>C variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at